Meiyue Li

Statistics

Publications

Citations

122

H-Index

Active since

2019

Affiliations

First Affiliated Hospital of Fujian Medical University(Current)

Fujian Medical University

University of California, San Francisco

Meiyue Li is an author at First Affiliated Hospital of Fujian Medical University specializing in healthcare cost analysis, pharmacoeconomics, and oncology.

Publications per year

2019–2021

Publications

miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7

Fei Guo, Kai Zhang, Meiyue Li et al. · International Journal of Oncology · 2020 · 43 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cost‐Utility Analysis of Pembrolizumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer With Different PD-L1 Expression Levels

Xiuhua Weng, Shaohong Luo, Shen Lin et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2019 · 32 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Cost-Effectiveness Analysis of Hepatic Arterial Infusion of FOLFOX Combined Sorafenib for Advanced Hepatocellular Carcinoma With Portal Vein Invasion

Meiyue Li, Lin Shen, Leslie Wilson et al. · Frontiers in Oncology · 2021 · 24 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

<scp>First-Line</scp> Durvalumab in Addition to Etoposide and Platinum for <scp>Extensive-Stage</scp> Small Cell Lung Cancer: A U.S.-Based <scp>Cost-Effectiveness</scp> Analysis

Shen Lin, Shaohong Luo, Dian Gu et al. · The Oncologist · 2021 · 23 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-effectiveness Analysis +16

1–4 of 4